Immediate breast reconstruction does not lead to a delay in the delivery of adjuvant chemotherapy.
Immediate breast reconstruction (IBR) has been considered by some to lead to a delay in the delivery of adjuvant chemotherapy. Our aim was to determine whether IBR led to a delay when compared to conservation surgery and non-reconstructive mastectomy. Ninety-five cases of IBR receiving chemotherapy were reviewed. These were compared to 95 consecutively treated patients undergoing conservation surgery and 95 undergoing non-reconstructive mastectomy. Our data shows that IBR does not lead to a delay in the delivery of adjuvant chemotherapy when compared to standard non-reconstructive surgery and should not adversely affect breast cancer outcome.
Wilson
C R
CR
Department of Surgery, Western Infirmary, University of Glasgow, Dumbarton Road, Glasgow G11 6NT, UK. dr37d@udcf.gla.ac.uk
Brown
I M
IM
Weiller-Mithoff
E
E
George
W D
WD
Doughty
J C
JC
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000601:surgery*; D017024:Chemotherapy, Adjuvant / Q000379:methods; D015331:Cohort Studies; D005260:Female; D006801:Humans; D016462:Mammaplasty / Q000379:methods*; D008408:Mastectomy / Q000379:methods; D013997:Time Factors
D000970:Antineoplastic Agents